Progress in the prevention of cytomegalovirus infection after allogeneic bone marrow transplantation
Related Experiment Videos
A Devergie1, R Traineau, H Esperou-Bourdeau
1Service de Greffe de Moelle, Hôpital Saint Louis, Paris, France.
Nouvelle Revue Francaise D'Hematologie
|January 1, 1994
Abstract:
There has been substantial progress in preventing and treating CMV infection. Prophylaxis with CMV screened blood products, IVIG and antiviral drugs (high dose acyclovir and/or Ganciclovir) considerably reduce the incidence of CMV disease and nearly eliminate CMV pneumonia after allogeneic BMT.